Browse CATs

Browse CATs  internal medicine  haematology  anticoagulation

Economics Prognosis Therapy Bleeding Heparin LMWH Warfarin

Anticoagulation a multicomponent intervention does not clearly reduce major bleeding in the elderly Level of evidence 1b- Expiry Date October 2003 Anticoagulation oral vitamin K controls a supratherapeutic INR better than placebo and leads to less bleeding Level of evidence 1b Expiry Date October 2003 Anticoagulation primary-care based management was as safe and effective as hospital-based management. Level of evidence 1b Expiry Date October 2003 Anticoagulation iv vitamin K lowered INR faster than sc vitamin K Level of evidence 1b Expiry Date October 2003 Anticoagulation warfarin plus vitamin K decreased INR faster than warfarin discontinuation. Level of evidence 1b Expiry Date June 2002 Anticoagulation 0.5 mg vitamin K iv effectively reversed INR >5.0. Level of evidence 4 Expiry Date June 2002 Warfarin therapy clotting factor concentrates may be more effective than fresh frozen plasma in decreasing INR quickly. Level of evidence 2b Expiry Date June 2003 Warfarin therapy INR took between 5 and 8 days after discontinuation to reach 1.2. Level of evidence 2b Expiry Date June 2003